The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.
CNBC's "The Exchange" discusses whether international markets may be able to sustain its 2025 outperformance through 2026 with "Fast Money" trader Tim Seymour of Seymour Asset Management Got a ...